general_pathology:immunology:innate_immunity_14
Differences
This shows you the differences between two versions of the page.
| general_pathology:immunology:innate_immunity_14 [2026/03/15 01:48] – created achamings | general_pathology:immunology:innate_immunity_14 [2026/03/15 01:51] (current) – achamings | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| < | < | ||
| - | < | + | < |
| </ | </ | ||
| < | < | ||
| < | < | ||
| + | The aim of TLRs with non-Myd88 pathways is to produce interferon as well as cytokines hence why they activate IRF (Interferon regulatory factor) as well as NF-κB. | ||
| {{ : | {{ : | ||
| </ | </ | ||
| </ | </ | ||
general_pathology/immunology/innate_immunity_14.1773539328.txt.gz · Last modified: by achamings
